InsidersTradesSigma
Follow the NEUROCRINE BIOSCIENCES, INC. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was filed on 9 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: DARIN LIPPOLDT. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations